Filing Details
- Accession Number:
- 0001225208-22-011139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-26 16:51:02
- Reporting Period:
- 2022-10-24
- Accepted Time:
- 2022-10-26 16:51:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1904791 | William Hait | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-10-24 | 15,000 | $90.44 | 95,236 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-10-24 | 1,187 | $171.55 | 94,049 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-10-24 | 13,813 | $171.55 | 80,236 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2022-10-24 | 15,000 | $0.00 | 15,000 | $90.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,698 | 2017-02-11 | 2024-02-09 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $171.52 to $171.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
